StartBBN • SWX
add
Bellevue Group AG
Seneste lukkekurs
14,00 CHF
Dagsinterval
14,00 CHF - 14,25 CHF
Årsinterval
11,05 CHF - 24,15 CHF
Markedsværdi
190,48 mio. CHF
Gns. volumen
11,19 t
P/E-værdi
12,76
Udbytteprocent
8,13 %
Primær børs
SWX
Markedsnyheder
Økonomi
Resultatopgørelse
Indtægt
Nettoindtægt
(CHF) | jun. 2024info | År til år-ændring |
---|---|---|
Indtægt | 18,41 mio. | -11,31 % |
Driftsudgifter | 13,73 mio. | -10,56 % |
Nettoindtægt | 3,72 mio. | -7,22 % |
Overskudsgrad | 20,18 | 4,61 % |
Earnings per share | — | — |
EBITDA | — | — |
Effektiv afgiftssats | 17,26 % | — |
Årsbalance
Samlede aktiver
Samlede passiver
(CHF) | jun. 2024info | År til år-ændring |
---|---|---|
Kontanter og korttidsinvesteringer | 30,49 mio. | 100,63 % |
Samlede aktiver | 138,75 mio. | -4,69 % |
Samlede passiver | 22,05 mio. | -24,81 % |
Samlet egenkapital | 116,70 mio. | — |
Shares outstanding | 13,20 mio. | — |
Kurs/indre værdi | 1,58 | — |
Afkast af aktiver | 10,71 % | — |
Afkast af kapital | — | — |
Pengestrøm
Nettoændring i likviditet
(CHF) | jun. 2024info | År til år-ændring |
---|---|---|
Nettoindtægt | 3,72 mio. | -7,22 % |
Pengestrøm fra drift | 3,65 mio. | 137,31 % |
Pengestrøm fra investering | — | — |
Pengestrøm fra finansiering | -8,10 mio. | 45,85 % |
Nettoændring i likviditet | -4,17 mio. | 83,13 % |
Fri pengestrøm | — | — |
Om
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.
Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
Administrerende direktør
Grundlagt
1993
Website
Ansatte
88